Irvine-headquartered Edwards Lifesciences has successfully completed the sale of its Critical Care product group to BD ...

Shares of Edwards Lifesciences Corp. EW inched 0.14% higher to $65.84 Thursday, on what proved to be an all-around mixed ...

In a significant financial move in the pharmaceutical industry, Edwards Life Sciences has sold its Critical Care division to Becton Dickinson (BD) for $4,200 million. The transaction, legally executed ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A ...

(Yicai) Nov. 8 -- Edwards Lifesciences will accelerate the introduction of new cardiovascular products into China after the ...

Jinhua Zhao is the Edward and Joyce Linde Associate Professor of City and Transportation Planning at the Massachusetts ...

Investors learned the truth on July 24, 2024, when Edwards Lifesciences announced its Q2 2024 financial results. Among other things, the company revealed that its TAVR sales grew just 5% and slashed ...

He clashed publicly with prominent atheists, including Richard Dawkins, and gave testimony in a famous court case in Arkansas ...

NEW YORK, NY / ACCESSWIRE / October 30, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and ...

Even though Democrat Caleb Rudow wasn't able to oust Republican Chuck Edwards from Congress, his campaign likely helped other ...

Line-up includes former Hospital Authority chairman Edward Leong and Nobel Prize winner Roger Kornberg of Stanford University ...